Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dow Corning Asks Judge To Rule Against Breast Implant Plan Modification

This article was originally published in The Gray Sheet

Executive Summary

Payments to the 94% of silicone breast implant claimants who agreed to the Dow Corning Joint Plan of Reorganization should begin soon provided a recent decision by the U.S. Bankruptcy Court to modify the plan is retained.

You may also be interested in...

Breast Implant Litigation

Proponents of the Dow Corning Joint Plan of Reorganization will present evidence at a June 28 confirmation hearing in the U.S. Bankruptcy Court in Bay City, Michigan in an effort to obtain approval on the plan from the court. On June 1, the Tort Claimants Committee and Dow Corning announced acceptance of the settlement proposal. With more than 300,000 claimant votes submitted on various claim categories, 94% voted in favor of the plan. Court confirmation would allow claimants to select the settlement method for their claim and would resolve the company's Chapter 11 filing

Novartis Holds Out For Happier Second Half Of 2020

The fourth quarter proved to be challenging for Novartis, with its dermatology, ophthalmology and oncology products – and Zolgensma – feeling the impact of COVID-19 lockdowns. The company is hoping for much better things in the second part of 2021.

How Pharma Can Navigate Ups And Downs Of Vertical Integration In US

Together, we will improve patient health and experiences while lowering costs across the continuum of care.” This quote, from Andrew Witty, CEO of US health services management company Optum, after the company sealed its acquisition of DaVita Medical Group in 2019, encapsulates the oft-declared goals of vertical integration: efficiencies, improved quality of care, reduced costs. But is this the reality?




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts